For example, ISL1 has been reported as an important regulator and potential therapeutic target for gastric cancer and triple-negative breast cancer76,77, while OTP has been characterized as a promising prognostic marker of pulmonary neuroendocrine tumors78. This evidence concerns the gene OTP and gastric cancer.